224 related articles for article (PubMed ID: 32909942)
1. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.
Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P
Elife; 2020 Sep; 9():. PubMed ID: 32909942
[TBL] [Abstract][Full Text] [Related]
2. Soluble Collectin-12 (CL-12) Is a Pattern Recognition Molecule Initiating Complement Activation via the Alternative Pathway.
Ma YJ; Hein E; Munthe-Fog L; Skjoedt MO; Bayarri-Olmos R; Romani L; Garred P
J Immunol; 2015 Oct; 195(7):3365-73. PubMed ID: 26290605
[TBL] [Abstract][Full Text] [Related]
3. Properdin binding to complement activating surfaces depends on initial C3b deposition.
Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Vuagnat BB; Mach J; Le Doussal JM
Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
[TBL] [Abstract][Full Text] [Related]
5. The role of properdin in the assembly of the alternative pathway C3 convertases of complement.
Hourcade DE
J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
Agarwal S; Ferreira VP; Cortes C; Pangburn MK; Rice PA; Ram S
J Immunol; 2010 Jul; 185(1):507-16. PubMed ID: 20530262
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
8. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
9. Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.
Michels MAHM; van de Kar NCAJ; van den Bos RM; van der Velden TJAM; van Kraaij SAW; Sarlea SA; Gracchi V; Oosterveld MJS; Volokhina EB; van den Heuvel LPWJ
Front Immunol; 2019; 10():1350. PubMed ID: 31263464
[TBL] [Abstract][Full Text] [Related]
10. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
[TBL] [Abstract][Full Text] [Related]
11. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.
Hebecker M; Józsi M
J Biol Chem; 2012 Jun; 287(23):19528-36. PubMed ID: 22518841
[TBL] [Abstract][Full Text] [Related]
12. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
mBio; 2011; 2(5):. PubMed ID: 21878570
[TBL] [Abstract][Full Text] [Related]
13. The role of properdin in zymosan- and Escherichia coli-induced complement activation.
Harboe M; Garred P; Lindstad JK; Pharo A; Müller F; Stahl GL; Lambris JD; Mollnes TE
J Immunol; 2012 Sep; 189(5):2606-13. PubMed ID: 22851705
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).
Saggu G; Cortes C; Emch HN; Ramirez G; Worth RG; Ferreira VP
J Immunol; 2013 Jun; 190(12):6457-67. PubMed ID: 23677468
[TBL] [Abstract][Full Text] [Related]
15. The Role of Properdin in Killing of Non-Pathogenic
Martinez APG; Abreu PAE; de Arruda Vasconcellos S; Ho PL; Ferreira VP; Saggu G; Barbosa AS; Isaac L
Front Immunol; 2020; 11():572562. PubMed ID: 33240263
[TBL] [Abstract][Full Text] [Related]
16. The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway.
Michels MAHM; Maas RJF; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ; Volokhina EB;
J Immunol; 2021 Nov; 207(10):2465-2472. PubMed ID: 34635587
[TBL] [Abstract][Full Text] [Related]
17. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
Front Immunol; 2020; 11():1643. PubMed ID: 32849563
[No Abstract] [Full Text] [Related]
18. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
Johnson U
Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
[TBL] [Abstract][Full Text] [Related]
19. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.
Alcorlo M; Tortajada A; Rodríguez de Córdoba S; Llorca O
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13504-9. PubMed ID: 23901101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]